Building a comprehensive understanding of socio-economic and human rights factors to disease outbreaks, drawing upon and partnering with communities most affected by diseases.
In February 2021, Matahari and the AIDS and Rights Alliance of Southern Africa (ARASA) held a roundtable with 20 Black and Brown leaders in global health, including communities living with diseases, academics, and those working within global health agencies, to catalyse ideas on an in-depth study on racism and white supremacy in global health.
The product of these discussions are shown in this inception report, including insights on how global health continues to be dominated by white supremacy, that it continues to be difficult for Black and Brown people to call out racism in global health as fear of retaliation is real, and of the ambivalence of white supremacy in global health – notably that ‘white liberals are allies until their privilege is threatened’.
Access the report below.
Matahari worked with the Alliance For Public Health to document the impact of COVID-19 on HIV and TB services in Bosnia and Herzegovina, Georgia, Kyrgyzstan, Moldova, Russian Federation, and Ukraine. We spoke to clinicians, communities living with HIV and TB, leaders in the COVID-19 response, and civil society experts – and found that:
Findings in this report were used in discussions on social support to HIV and TB communities in Moldova, and crucially were used to update government TB Mitigation Plans in Ukraine.
All country reports are available at This Link.
Media about this report:
Health Policy Watch (8 April 2021): Https://Healthpolicy-Watch.news/Hiv-And-Tb-Patients-Face-New-Barriers/
Kommersant/Коммерса́нтъ (10 April 2021): Https://Www.kommersant.ru/Doc/4769937
Matahari worked with the International Treatment Preparedness Coalition (ITPC) to document the Brazilian COVID-19 Response through 2020, which has been marked by high death numbers, misinformation coming from the highest levels of government, disparities in access to health services for indigenous populations, and shortages of essential health technologies.
Read more about our findings at this link.